Activating mutations of the epidermal growth factor receptor gene (EGFR) have been detected in 30–40% of NSCLC tumors in Asian patients and in 10–15% of those in patients of European descent2,3. This evidence concerns the gene EGFR and non-small cell lung carcinoma.